Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Neurology
  4. Rapid healing of a patient with dramatic subacute combined degeneration of spinal cord: a case report

Rapid healing of a patient with dramatic subacute combined degeneration of spinal cord: a case report

BMC Res Notes, 2017 · DOI: 10.1186/s13104-016-2344-4 · Published: January 18, 2017

NeurologyNutrition & DieteticsResearch Methodology & Design

Simple Explanation

This case report describes a patient with subacute combined degeneration of the spinal cord (SACD) due to cobalamin (vitamin B12) deficiency, even with normal cobalamin serum levels. The patient's condition rapidly improved with cobalamin supplementation. The patient initially presented with neurological symptoms, but standard blood tests for cobalamin were normal. Further testing revealed elevated methylmalonic acid (MMA) and homocysteine levels, indicating a cobalamin deficiency. The cause of the cobalamin deficiency was found to be autoimmune gastritis, which impaired the absorption of cobalamin. Treatment with cobalamin injections led to a rapid recovery.

Study Duration
11 Months
Participants
1 Caucasian man, 57 years old
Evidence Level
Level 4: Case Report

Key Findings

  • 1
    Normal cobalamin serum levels do not rule out a cobalamin deficiency, especially in cases of SACD.
  • 2
    Elevated MMA and homocysteine levels can be indicative of cobalamin deficiency even when cobalamin serum levels are normal.
  • 3
    Early cobalamin substitution can reverse pathological changes in the spinal cord and resolve associated clinical symptoms of SACD.

Research Summary

This case report highlights the diagnostic challenges of cobalamin deficiency, particularly in patients with SACD, and emphasizes the importance of considering alternative markers like MMA and homocysteine when cobalamin levels are normal. The patient's rapid recovery following cobalamin supplementation underscores the importance of early and appropriate treatment to reverse neurological damage associated with cobalamin deficiency. The case also illustrates the need to investigate underlying causes of cobalamin deficiency, such as autoimmune gastritis, to ensure appropriate long-term management.

Practical Implications

Diagnostic Approach

In patients presenting with neurological symptoms suggestive of SACD, consider testing MMA and homocysteine levels even if cobalamin levels are within the normal range.

Treatment Strategy

Initiate cobalamin supplementation promptly in patients diagnosed with cobalamin deficiency, tailoring the dosage and administration route to the underlying cause and severity of the deficiency.

Etiology Investigation

Investigate the underlying cause of cobalamin deficiency, such as autoimmune gastritis, to guide long-term management and prevent recurrence.

Study Limitations

  • 1
    Single case report limits generalizability
  • 2
    HoloTC was not measured
  • 3
    Limited information on long-term follow-up beyond 11 months

Your Feedback

Was this summary helpful?

Back to Neurology